Exploring Outcomes and Characteristics of Myasthenia Gravis 2
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard Nowak, MD
Yale University
Principal Investigator - Vern Juel, MD
Duke University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California-Irvine
Irvine, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Yale University
New Haven, Connecticut, United States
- George Washington University
Washington D.C., District of Columbia, United States
- University of Chicago
Chicago, Illinois, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Jan 2021
- Primary completion
- 31 May 2025
- Completion
- 31 May 2025
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 311
- Registry id
- NCT06002945
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.